Terumo Branches out in Endovascular Devices
Terumo's business to date has been mostly cardiovascular, with a growing US and European business in devices for peripheral vascular disease. But with aspirations to become a truly global player, Terumo officials know they have to expand and round out their product line. The acquisition this month of Orange County, CA-based MicroVention Inc. is an important step in that direction, giving the Japanese giant a foothold in the one vascular business it doesn't have a significant stake in: interventional neuroradiology.
You may also be interested in...
Valor Medical Inc.
Valor Medical treats cerebral aneurysms with Neucrylate, which is injected through a microinfusion catheter introduced into the femoral artery of the leg, then passed up through the arterial system into the brain. Neucrylate is slowly delivered to the aneurysm in liquid form via a syringe. Once the product makes contact with blood, it immediately polymerizes into a soft, spongy solid to permanently relieve the blood pressure of the vessel wall of the aneurysm.
Business & Technology Briefs (03/2007)
Brief summaries of recent product and clinical developments in the device industry, including developments in Cardiac and Peripheral Devices, Miniature Robotic Devices, and Diabetes Management.
Where are They Now? Yesterday's Stroke Companies
In May 2000, START-UP profiled five medical device companies targeting stroke, in an article entitled "Making Progress in Stroke." We recently revisited Radiant Medical, Medivance, MicroVention, and two others to find out what went according to plan and what didn't In 2007, we have to say that there has in fact not been much progress, at least in acute ischemic stroke. Two companies dropped out, two remain active with promising programs--in clinical areas other than stroke, and one, which avoided ischemic stroke in the first place, enjoyed a nice exit.